Effects of Subcutaneous and Intravenous Recombinant Human Erythropoietin Treatments on Body Iron in Rats
Recombinant human erythropoietin (rHuEPO) is used widely in clinical practice for correcting anemia related to renal failure, cancer chemotherapy, HIV infection, premature infants, and chronic diseases. Recombinant human erythropoietin is known to affect body iron status that may result in functiona...
Saved in:
Main Author: | Ahmed Shujaaedin, Hareth Yahya |
---|---|
Format: | Thesis |
Language: | English English |
Published: |
2009
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/11540/1/FPV_2009_15.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
by: Shujaaedin, Hareth Yahya Ahmed
Published: (2019) -
Characterisation of Induced Rat Mammary Gland Tumor and the Antitumor Effect of Recombinant Human Erythropoietin and Tamoxifen
by: Abdul Karim, Sairah
Published: (2009) -
Detection of iron deficiency anaemia by retic haemoglobin
(ret-he) in haemodialysis patients on recombinant human
erythropoietin (rHuEPO).
by: Ehram, Jamian
Published: (2010) -
Comparison Of Analgesic Effect Of Subcutaneous Bupivacaine Infiltration And Intravenous Diclofenac Vs. Intravenous Diclofenac Alone In Inguinal Hernioplasty: A Retrospective, Single Centre Study In Gaza
by: S Alijla, Said S
Published: (2023) -
Characterisation and expression optimisation of recombinant human erythropoietin produced in the methylotrophic yeast pichia pastoris /
by: Teh, Ser Huy
Published: (2011)